Follow

An interesting detail in this @biorxivpreprint from @iannaconelab on the Nirmatrelvir is that they (the researchers) produced the molecule in-house:

"Nirmatrelvir was synthesized prior to its publication (4) via a multistep convergent approach that differed from the reported procedure (3, 17, 18). Details and synthesis intermediates are shown in Figure 1A and in Materials and Methods."

biorxiv.org/content/10.1101/20

I spoke with the senior author, Matteo Iannacone of in Milan for the earlier this year about models for research, including dramatic differences between aerosol vs intranasal exposure to the virus in mice - the of the disease is very different.

embo.org/podcasts/embo-young-i

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.